Buparlisib (BKM120)
Buparlisib (BKM120, NVP-BKM120) is a selective PI3K inhibitor of p110α/β/δ/γ with IC50 of 52 nM/166 nM/116 nM/262 nM in cell-free assays, respectively. Reduced potency against VPS34, mTOR, DNAPK, with little activity to PI4Kβ. Buparlisib induces apoptosis. Phase 2.
Trivial name | NVP-BKM120 |
Catalog Number | S2247 |
Molecular Formula | C18H21F3N6O2 |
CAS# | 944396-07-0 |
Inchi | InChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23) |
Inchi Key | CWHUFRVAEUJCEF-UHFFFAOYSA-N |
SMILES | C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4 |
Size | 5mg |
Supplier Page | http://www.selleckchem.com/products/BKM-120.html |
Additional Information | https://file.selleck.cn/downloads/struct/s2247-buparlisib-bkm120-chemical-structure.png |